Transforming growth factor- <i>beta</i> is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.
1988 · The Journal of Immunology · 389 citations
https://doi.org/10.4049/jimmunol.140.9.3026
G
Geoffrey Hall
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
1.6K
Citations
18
h-index
20
i10-index
Geoffrey Hall is an academic researcher. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Bladder and Urothelial Cancer Treatments & Virus-based gene therapy research. The author has an h-index of 18, co-authored 40 publications.
Papers by this author
worksWhy NHS hospital co-morbidity research may be wrong: how clinical coding fails to identify the impact of diabetes mellitus on cancer survival
2025 · British Journal of Cancer · 0 citations
https://doi.org/10.1038/s41416-025-03136-9
Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by BRCA status: a retrospective cohort study
2026 · ESMO Real World Data and Digital Oncology · 0 citations
https://doi.org/10.1016/j.esmorw.2025.100659
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat